Physician profile
Chi Dai Chen
NPI 1033294285
$1,139.54
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,093 · 2020: $46.59.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $895.40 | 2019 | |
| Novo Nordisk INC | $53.10 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $31.86 | 2019 | |
| Polarityte, INC. | $31.19 | 2019 | |
| Genentech USA, INC. | $30.00 | 2019-2020 | |
| Kci USA, INC. | $21.20 | 2020 | |
| Amgen INC. | $19.00 | 2019 | |
| Smith+Nephew, INC. | $17.19 | 2019 | |
| Amarin Pharma, INC. | $15.58 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.75 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.27 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chi Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.